TELA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TELA Bio Inc is not a strong buy for a beginner, long-term investor at this moment. While the company has shown revenue growth, its financial performance is weak with declining net income, EPS, and gross margin. Additionally, there are no significant positive catalysts or trading signals to justify immediate investment. The technical indicators are neutral, and the options data does not indicate strong sentiment. For a long-term investor, this stock may not align with the desired stability and growth potential.
The MACD is slightly positive at 0.0156, but contracting. RSI is neutral at 54.925. Moving averages are converging, indicating no clear trend. Key support is at 0.725, and resistance is at 0.908. The stock has an 80% chance to decline -1.87% in the next day but a 12.44% chance to rise in the next month.
The stock has a 12.44% chance of gaining in the next month.
Net income dropped by -17.06% YoY, EPS declined by -54.76% YoY, and gross margin decreased slightly. No recent news, no significant insider or hedge fund activity, and no congress trading data. Analyst sentiment and valuation data are unavailable.
In Q3 2025, revenue increased to $20.69M (+9.14% YoY), but net income dropped to -$8.6M (-17.06% YoY). EPS fell to -0.19 (-54.76% YoY), and gross margin decreased slightly to 67.52% (-0.46% YoY).
No recent analyst ratings or price target changes available.
